I think even if there were self reported sight improvements they would not be able to disclose that until the trial design specified testing date had taken place ... its a frustrating wait I know.
- Forums
- ASX - By Stock
- PYC
- Ann: RP11 Drug Candidate Safe and Well Tolerated
PYC
pyc therapeutics limited
Add to My Watchlist
1.93%
!
$1.27

Ann: RP11 Drug Candidate Safe and Well Tolerated, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
-0.025(1.93%) |
Mkt cap ! $737.8M |
Open | High | Low | Value | Volume |
$1.31 | $1.31 | $1.27 | $2.469M | 1.908M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 8032 | $1.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.27 | 4485 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 8032 | 1.260 |
2 | 1089 | 1.255 |
1 | 700 | 1.250 |
1 | 216 | 1.240 |
1 | 181 | 1.235 |
Price($) | Vol. | No. |
---|---|---|
1.270 | 4485 | 3 |
1.275 | 11236 | 4 |
1.280 | 29562 | 3 |
1.285 | 1134 | 1 |
1.290 | 2510 | 2 |
Last trade - 12.51pm 28/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online